Observational Study Evaluating the LDL-C [low density lipoprotein cholesterol] Lowering Effects of Ezetimibe With a Statin [HMG-CoA reductase inhibitor] as Prescribed in Daily Routine Practice in an Indonesian Population.
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2014
At a glance
- Drugs Ezetimibe (Primary) ; HMG-CoA reductase inhibitors
- Indications Hypercholesterolaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 05 Aug 2009 Actual patient number (453) added as reported by ClinicalTrials.gov.
- 21 Jul 2008 New trial record.